These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 39222901)
1. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production. Chen YJ; Guo ZT; Chen HQ; Zhang SF; Bao YX; Xie Z; Ke JL; Ye WJ; Liang JC; Chen JC; Li N; Zheng FX; Liao H; Wu T; Pang JX Chem Biol Interact; 2024 Nov; 403():111220. PubMed ID: 39222901 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents. Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987 [TBL] [Abstract][Full Text] [Related]
3. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255 [TBL] [Abstract][Full Text] [Related]
4. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251 [TBL] [Abstract][Full Text] [Related]
5. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1. Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420 [TBL] [Abstract][Full Text] [Related]
6. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters. Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683 [TBL] [Abstract][Full Text] [Related]
7. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645 [TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice. Chen G; Tan ML; Li KK; Leung PC; Ko CH J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851 [TBL] [Abstract][Full Text] [Related]
9. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705 [TBL] [Abstract][Full Text] [Related]
10. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3. Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456 [TBL] [Abstract][Full Text] [Related]
11. Ilex cornuta leaves extracts ameliorate hyperuricemia by modulating uric acid transporters. Mao Y; Xu H; Xia P J Ethnopharmacol; 2025 Jan; 336():118618. PubMed ID: 39069031 [TBL] [Abstract][Full Text] [Related]
12. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models. Li X; Yan Z; Tian J; Zhang X; Han H; Ye F Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426 [TBL] [Abstract][Full Text] [Related]
13. Chen J; Xu L; Jiang L; Wu Y; Wei L; Wu X; Xiao S; Liu Y; Gao C; Cai J; Su Z Food Funct; 2021 Oct; 12(19):9416-9431. PubMed ID: 34606558 [No Abstract] [Full Text] [Related]
14. Hypouricemic Effects of Extracts from Han S; Wei R; Han D; Zhu J; Luo W; Ao W; Zhong G Biomed Res Int; 2020; 2020():2968135. PubMed ID: 32083126 [No Abstract] [Full Text] [Related]
15. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice. You W; Wang J; Zou Y; Che K; Hou X; Fei H; Wang Y J Int Med Res; 2019 May; 47(5):1927-1935. PubMed ID: 30832523 [TBL] [Abstract][Full Text] [Related]
16. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney. Lee YS; Sung YY; Yuk HJ; Son E; Lee S; Kim JS; Kim DS Phytomedicine; 2019 Sep; 62():152975. PubMed ID: 31181404 [TBL] [Abstract][Full Text] [Related]
17. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. Jiao L; Wang R; Dong Y; Su J; Yu J; Yan M; Chen S; Lv G J Ethnopharmacol; 2024 Oct; 333():118488. PubMed ID: 38925319 [TBL] [Abstract][Full Text] [Related]
18. Sleeve gastrectomy ameliorates renal injury in obesity-combined hyperuricemic nephropathy mice by modulating the AMPK/Nrf2/ABCG2 pathway. Song K; Kong X; Zhang Z; Xian Y; He M; Zhang Y; Liao X; Huang Z; Kang A; Xiao D; Ren Y Sci Rep; 2024 Oct; 14(1):22834. PubMed ID: 39354116 [TBL] [Abstract][Full Text] [Related]
19. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis. Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377 [TBL] [Abstract][Full Text] [Related]
20. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice. Wu X; Huang R; Ai G; Chen H; Ma X; Zhang J; Huang Q; Lao J; Zeng H; Li C; Xie J; Li Y; Su Z; Chen J; Huang X J Ethnopharmacol; 2024 Dec; 335():118606. PubMed ID: 39038504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]